Ana Marta Gomes

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Deciphering the Contribution of Biofilm to the Pathogenesis of Peritoneal Dialysis Infections: Characterization and Microbial Behaviour on Dialysis Fluids

Joana Sampaio, Diana Machado, Ana Marta Gomes et al. · PLoS ONE · 2016 · 63 citations · Full text

Dialysis Therapy, Bacterial Pathogenesis, Biofilms +16

Minimal Clinically Important Differences for Measures of Pain, Lung Function, Fatigue, and Functionality in Spinal Cord Injury

Margarida Sobreira, Miguel P. Almeida, Ana Marta Gomes et al. · Physical Therapy · 2020 · 21 citations · Full text

Hemolytic uremic syndrome as a primary manifestation of acute human immunodeficiency virus infection

Ana Marta Gomes, Alessandro Ventura, Cibele Taís Puato de Almeida et al. · Clinical Nephrology · 2009 · 14 citations

Immunology, Hemolytic Uremic Syndrome, Human Immunodeficiency Virus +16